# Olema Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 21:07 ET
- Period: 2023-12-31
- Accession: 0000950170-24-049287
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000095017024049287/olma-def_14a-2024_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000095017024049287/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000095017024049287/olma-def_14a-2024_proxy.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049287. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.